meglitinide has been researched along with Liver Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arvind, A; Corey, KE; Memel, ZN; Philpotts, LL; Simon, TG; Zheng, H | 1 |
1 review(s) available for meglitinide and Liver Neoplasms
| Article | Year |
|---|---|
Thiazolidinediones, alpha-glucosidase inhibitors, meglitinides, sulfonylureas, and hepatocellular carcinoma risk: A meta-analysis.
Topics: Aged; Benzamides; Carcinoma, Hepatocellular; Diabetes Mellitus, Type 2; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Incidence; Liver Neoplasms; Middle Aged; Risk Factors; Sulfonylurea Compounds; Thiazolidinediones | 2021 |